Effects of dyslipidemia and smoking on macrovascular disease in type 2 diabetes

被引：0
|
作者：
Herskovits, AT
Chajek-Shaul, T
机构：
来源：
DIABETES | 1998年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1406
引用
收藏
页码：A364 / A364
页数：1
相关论文
共 50 条
  • [21] Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort
    Yokomichi, Hiroshi
    Nagai, Akiko
    Hirata, Makoto
    Kiyohara, Yutaka
    Muto, Kaori
    Ninomiya, Toshiharu
    Matsuda, Koichi
    Kamatani, Yoichiro
    Tamakoshi, Akiko
    Kubo, Michiaki
    Nakamura, Yusuke
    Yamagata, Zentaro
    [J]. JOURNAL OF EPIDEMIOLOGY, 2017, 27 (03) : S98 - S106
  • [22] Dyslipidemia in type 2 diabetes
    Krauss, RM
    Siri, PW
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (04) : 897 - 909
  • [23] Macrovascular disease in type 1 diabetes mellitus: Effects of intensified insulin treatment
    Diem, P
    Steffes, MW
    Egger, M
    [J]. DIABETES, 2001, 50 : A152 - A152
  • [24] Type 2 Diabetes Mellitus, Dyslipidemia, and Alzheimer's Disease
    Carlsson, Cynthia M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (03) : 711 - 722
  • [25] Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus
    Rhee, Sang Youl
    Kim, Young Seol
    Chon, Suk
    Oh, Seungjoon
    Woo, Jeong-taek
    Kim, Sung Woon
    Kim, Jin-Woo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 91 (01) : E11 - E14
  • [26] Macrovascular disease in elderly patients with Type 1 diabetes
    Purvis, T. E.
    Anderson, M. J.
    Bhattacharjee, R.
    Chapman, M. J.
    Crockett, S. C.
    Whittaker, P. L.
    Marshall, T.
    Niranthakumar, K.
    [J]. DIABETIC MEDICINE, 2013, 30 : 88 - 88
  • [27] Type 2 Diabetes Mellitus and Macrovascular Complications
    Shan, Peng-Fei
    Li, Qian
    Khamaisi, Mogher
    Qiang, Gui-fen
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [28] Genetics of macrovascular complications in type 2 diabetes
    Tonyan, Ziravard N.
    Nasykhova, Yulia A.
    Danilova, Maria M.
    Glotov, Andrey S.
    [J]. WORLD JOURNAL OF DIABETES, 2021, 12 (08) : 1200 - 1219
  • [29] Risk factors for macrovascular disease in type 2 diabetes - Classic lipid abnormalities
    Steiner, G
    [J]. DIABETES CARE, 1999, 22 : C6 - C9
  • [30] Diabetes and macrovascular disease
    Miettinen, H
    Salomaa, V
    [J]. CORONARY ARTERY DISEASE, 1996, 7 (10) : 708 - 714
12345